AQS Stock Forecast, Price & News (Aequus

1600 CAD-0. Get the latest AEQUUS PHARMACEUTICALS (AEQ. Market Insider works with public RSS feeds of best business news websites, personal blogs and provides automatically generated list of financial news links directly referring to its sources. · Proactive news headlines including Aequus Pharmaceuticals, Aurelius Minerals, Orogen Royalties and Mountain Valley MD Holdings Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Back to video. · Aequus Pharmaceuticals (OTCQB:AQSZF) is a growing specialty pharmaceutical company with an increasing pipeline of commercial products in ophthalmology and transplant, and a development stage. Aequus has grown its sales and marketing efforts to include several commercial products in. The health authority in British Columbia changed. NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U. Aequus Pharmaceuticals Inc AQS - Aequus Pharmaceuticals Inc Share News. 12, at 10:51 a. 0,34 % 32. Aequus Pharmaceuticals financial news headlines. AEQUUS PHARMACEUTICALS AKTIE und aktueller Aktienkurs. Find the latest news headlines from Aequus Pharmaceuticals Inc (AQSZF) at. V) on CEO. (AQSZF),. Currencies. 7m: Revenue: £1. News. Aequus Pharmaceuticals Inc. AEQUUS PHARMACEUTICALS AKTIE (ISIN: CA: Realtime-Kurs der Aequus Pharmaceuticals Aktie, Dividenden-Rendite und Termine, aktuelle Nachrichten ⇒ Die nächsten Kursziele. (TSX-V: AQS, OTCQB: AQSZF) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated quus has. Aequus Announces Positive Update on Dry Eye Product Launch Plans: Vancouver, BC, Ap--Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. 2 0. Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:New York, Ma (GLOBE NEWSWIRE) -- - First Cobalt Corp (CVE:FCC) (OTCQX:FTSSF) (FRA:18P) completes its Cobalt Camp transaction with Kuya Silver click here - First Mining Gold Corp (TSE:FF) (OTCQX:FFMGF) (FRA:FMG) strikes deal with Exiro. Home Homepage Membership Levels General Discussion Complete Stock List Value Investing Forum Value Conference The book Podcast Membership Data Coverage Founder's Message Free Trial. - January 16 at 5:28 PM. Aligning with Canadian clinicians, patients, and researchers to improve outcomes. It generates a majority of its revenue from the Commercial platform segment. 31m: Position in Universe: 1569th. Aequus Pharmaceuticals (AQS. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products announces Ms Anne Stevens is stepping down from her role as. Get the latest up-to-the minute news on Aequus Pharmaceuticals from ADVFN 20:13:37 Cookie PolicyFree Membership Login Monitor. (V. Ma. · Aequus Pharmaceuticals Inc. stock news by MarketWatch. Aequus in-licensed Canadian commercial rights to Topiramate XR from Supernus Pharmaceuticals and is currently preparing an application to Health Canada seeking approval. (OTCMKTS: AQSZF) Share Price and News. (AQS) stock price, news, historical charts, analyst ratings and financial information from WSJ. (TSX-V: AQS, OTCQB: AQSZF) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Sector Healthcare RiskRating. Its products include, Tacrolimus IR, are used for the treatment of. · AQSZF | Complete Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on advancing and promoting differentiated products is pleased to announce that. Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals, 08:22 ET. Aequus Pharmaceuticals Inc. , a specialty pharmaceutical company, develops and commercializes drugs in Canada. 00:04:56 1. Find the latest AEQUUS PHARMACEUTICALS INC (AQS. The firm's operating segments are Commercial platform and Development pipeline. CA, an investment chat community for Canada's small cap markets. Aequus Pharmaceuticals has a P/B Ratio of 38. , has been issued a new Medical Device License for the first of three product submissions made for the EvolveTM preservative. Aequus Pharmaceuticals Inc. MU) stock news and headlines to help you in your trading and investment decisions. · Press Release Proactive news headlines including Alpine 4 Technologies, Aequus Pharmaceuticals, Aurania Resources and VolitionRx Published: Feb. · The latest news and upcoming dividend, earnings, and split events for Aequus Pharmaceuticals Inc (AQSZF:US). Quote. Size Micro Cap Style Sucker Stock Market Cap: £12. Aequus is developing a pipeline of products in neurology and psychiatry. From GlobeNewswire News Releases. Free forex prices, toplists, indices and lots more. Aequus Receives Approval for New ‘Evolve - Intensive Gel’ Lubricating Eye Drops in Canada: Vancouver, BC, Octo--Aequus Pharmaceuticals Inc. Aequus has. Doug Janzen has been involved in the Life Sciences industry for the past 19 years. Mr Janzen was part of the founding group of Aequus Pharmaceuticals. Aequus Pharmaceuticals hails further boost to its growing Sandoz tacrolimus revenues across Canada - January 16 at 10:28 PM: NA Proactive news snapshot: Aequus Pharmaceuticals, Nano One Materials, Next Green Wave, Metalla Royalty & Streaming UPDATE. It was a big surprise for many shareholders when Aequus announced exciting news on 16th January. 0 0. Get the latest AEQUUS PHARMACEUTICALS INC (AQSZF) stock news and headlines to help you in your trading and investing decisions. The firm's operating segments are Commercial platform and Development pipeline. MarketBeat's community ratings are surveys of what our community members think about Aequus Pharmaceuticals and other stocks. (AQS. Aequus Pharmaceuticals has received 51. (TSX-V: AQS), a specialty pharmaceutical company announced that together with its partner, Medicom Healthcare Ltd. Aequus Pharmaceuticals Inc. DAX. News, commentary and events are from third-party sources unaffiliated with Fidelity. focuses on the development and commercialization of alternatives to currently approved drugs. Free forex prices, toplists, indices and lots more. - Faktenthread -' vom 31. Aequus Pharmaceuticals | 1,091 followers on LinkedIn. (TSX-V: AQS, OTCQB: AQSZF) (Aequus. Real-time discussion about Aequus Pharmaceuticals Inc. 15 per Unit, for aggregate gross proceeds of $1,000,000 to Marc Lustig, who has concurrently agreed to join. View the latest Aequus Pharmaceuticals Inc. Speculative. Share this article /NOT FOR DISTRIBUTION TO U. News provided by. (TSX-V: AQS, OTCQB: AQSZF) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /. , as distributed by Newsfile, a compliance solutions provider for public companies. 12, (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. Company profile page for Aequus Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information. View real-time stock prices and stock quotes for a full financial overview. S. 7m: Enterprise Value: £12. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and. Topiramate immediate release is currently approved in Canada for use in epilepsy and prophylactic migraine. Reg (AEQ. Latest news releases from Aequus Pharmaceuticals Inc. Free real-time prices, trades, and chat. Seite 180 der Diskussion 'Aequus Pharmaceuticals Inc. NEWSWIRE SERVICES VANCOUVER, British Columbia, Ap (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Aktie: WKN A2ASE5 - ISIN CAAktueller Aktienkurs, Charts, Nachrichten und Termine zu Aequus Pharmaceuticals. Aequus Pharmaceuticals has received 60 “underperform” votes. Nachrichten zur Aktie Aequus Pharmaceuticals Inc | A2ASE5 | AQSZF | CA. News Releases Vancouver, British Columbia--(Newsfile Corp. News releases from Aequus Pharmaceuticals < Previous 1 2 3 Next > Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada. (TSX-V: AQS, OTCQB: AQSZF) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated quus has. 398,8 ESTX50-0,12 %. Tickers AQS AQSZF. Aequus Pharmaceuticals (AQS) share price, charts, trades & the UK's most popular discussion forums. 0050 (-3. : News, information and stories for AEQUUS PHARMACEUTICALS INC. 4. (A2ASE5 | CAmit aktuellem Aktienkurs, Charts, News und Analysen. Aequus Pharmaceuticals (AQS) share price, charts, trades & the UK's most popular discussion forums. 12. im w:o-Forum 'Biotech'. is a growing specialty pharmaceutical company focused on developing and commercializing high quality. 45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Aequus Pharma Outlook and Holiday Wishes. Aequus Pharmaceuticals (QB) news and AQSZF price. 5 cents on Monday. 22% “outperform” votes from our community. März - Aequus Pharmaceuticals Inc. We are pleased to see such a large portion of the warrants be exercised, commented Doug Janzen, Aequus chairman and chief executive officer in a statement I personally increased my Aequus holdings by exercising 1,562,500 warrants at a cost of $187,500 and expect these funds to be used to advance. Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. | TSX VENTURE EXCHANGE: AQS | TSX VENTURE EXCHANGE. Home of the insider insights newsletter and the Canadian Insider Club which offers alerts and premium research. Aequus Pharmaceuticals, Inc. Aequus is a rapidly growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Fidelity makes no guarantees that information supplied is accurate, complete, or timely,. Fidelity does not endorse or adopt their content. Price to Book Value per Share Ratio. (TSX-V: AQS, OTCQB: AQSZF) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. 13:19:Free Membership Login. (Add your “underperform” vote. He is currently the Founder and President of Northview Ventures, an organization which invests in and provides strategic advisory services to a number of technology companies. Aequus has grown its pipeline to include several commercial products in ophthalmology and transplant, and a development stage pipeline in neurology. Stock analysis for Aequus Pharmaceuticals Inc (AQSZF:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Amendment on Earlier Release: Aequus Provides General Update and First Quarter Financial Highlights. Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. Get the latest Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products announced that it intends to complete a non-brokered private placement of 6,666,666 units of the Company at a price of $0. 0,53 % 15. 67 million units at a price of $0. Latest news headlines for Aequus Pharmaceuticals Inc with market analysis and analyst commentary. m. · Aequus Pharmaceuticals (TSX-V:AQS), A Rapidly Growing Specialty Pharma Company. C$0. International. Decem. AEQUUS PHARMACEUTICALS share price in real-time (A2ASE5 / CA, charts and analyses, news, key data, turnovers, company data. This has been achieved with just their two. · Proactive news headlines including Aequus Pharmaceuticals, Aurelius Minerals, Orogen Royalties and Mountain Valley MD Holdings. It generates a majority of its revenue from the Commercial platform segment. V), a specialty pharma company with a business model of acquiring and re-platforming existing approved biotech and health products to appeal to a wider market, has announced another win Monday morning with news Health Canada has approved the advancing of their Evolve dry-eye relief gel line to an easy-squeeze eye drop bottle. Aequus announces the commercial availability of Evolve TM preservative. Read all the latest Aequus Pharmaceuticals Inc NPV share news, regulatory announcements and tips. Aequus Pharmaceuticals News & Media Aequus Announces Anne Stevens’ Leadership Change VANCOUVER, British Columbia, Nov. · Aequus Pharmaceuticals (OTCQB:AQSZF). 186,5 TecDAX. SG) stock news and headlines to help you in your trading and investment decisions. AEQUUS PHARMACEUTICALS INC. 452,9 MDAX. - J) - Trading resumes in: Company: Aequus Pharmaceuticals Inc. Tickers AQS. AEQUUS PHARMACEUTICALS INC. Aequus Pharmaceuticals Inc (TSV: AQS ) 0. Find the latest AEQUUS PHARMACEUTICALS () stock quote, history, news and other vital information to help you with your stock trading and investing. MU) stock quote, history, news and other vital information to help you with your stock trading and investing. Proactive news headlines including Aequus Pharmaceuticals, Aurelius Minerals, Orogen Royalties and Mountain Valley MD Holdings Ma Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:. Aequus Pharmaceuticals Inc (OTCMKTS:AQSZF) (FRA:AEQ) said that it intends to complete a non-brokered private placement of around 6. Aequus Pharmaceuticals Inc. Aequus Provides update on Warrant Acceleration. Aequus Pharmaceuticals Inc. View real-time stock prices and stock quotes for a full financial overview. Aequus Pharmaceuticals Inc.  · 7 days Aequus Pharmaceuticals: New Products To Accelerate Growth In Seeking Alpha. · Aequus Pharmaceuticals Inc. · Aequus will publish their annual report around 23 April that is expected to report a revenue growth in the magnitude of +45% compared to. VANCOUVER, 23. Overview Detailed Quote Charting Historical Prices. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantatio. The pharmaceuticals company, which focuses on developing and commercializing. Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc. In depth view into Aequus Pharmaceuticals Market Cap including historical data from, charts, stats and industry comps. The P/E ratio of Aequus Pharmaceuticals is -10. is a Vancouver-based company, focused on enhancing delivery methods for approved drugs and select consumer products that are limited by non-compliance, high frequency dosing, first-pass metabolism side effects, painful injections, or where the commercial presentation can be improved by making a long acting alternative. 33. Get the latest AEQUUS PHARMACEUTICALS INC (AQSZF) stock news and headlines to help you in your trading and investing decisions. IRW-PRESS: Aequus Pharmaceuticals: Mitteilung des CEO von Aequus Pharmaceuticals. · Aequus Pharmaceuticals Inc. Company Analysis and Financial Data Status Unless specified all financial data is based on a yearly period but updated quarterly. ETGet the latest AEQUUS PHARMACEUTICALS () stock news and headlines to help you in your trading and investment decisions. Aequus Pharmaceuticals News: Hier finden Sie die News-Seite für den Wert Aequus Pharmaceuticals. Treasuries. · Aequus Pharmaceuticals Inc. V) stock quote, history, news and other vital information to help you with your stock trading and investing. Aequus’ sales and marketing efforts are based in Canada, targeting highly specialized therapeutic areas including neurology, ophthalmology and transplant. Aequus Provides Third Quarter Financial Highlights: Vancouver, BC, Decem--Aequus Pharmaceuticals Inc. Find the latest AEQUUS PHARMACEUTICALS INC (AQSZF) stock quote, history, news and other vital information to help you with your stock trading and investing. Aequus is developing a pipeline of products in neurology and psychiatry. Find the latest AEQUUS PHARMACEUTICALS (AEQ. All News News Headlines Press Releases. News. Aequus has. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, reported financial results for the three months ended Septem and associated Company developments. S. AQS) hit a new 52-week high of 27. Get stock quotes, news, fundamentals and easy to read SEC and SEDI insider filings. (V:AQS) | Canadian Insider. Find the latest AEQUUS PHARMACEUTICALS INC (AQSZF) stock quote, history, news and other vital information to help you with your stock trading and investing. ) Community Sentiment. Aequus Pharmaceuticals News: This is the News-site for the company Aequus Pharmaceuticals on Markets Insider. 0% Last Trade - 24/02/21. 7. | Aequus Pharmaceuticals (TSX-V: AQS, OTCQB: AQSZF) is a. 0,27 % 3. 15 each to raise $1 million as part of a direct equity investment by Marc Lustig, who has concurrently agreed to join the company’s board of directors. 03%) Streaming Delayed Price Updated: 3:43 PM EST, Add to My Watchlist. Aequus Pharmaceuticals Inc Stock News and Research Articles - : latest news, headlines and research articles. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced this week a positive update on the regulatory and launch advancement for its Evolve® line of preservative free dry eye products into. Aequus Pharmaceuticals Inc. stock news by MarketWatch. · AQS | Complete Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.